265 related articles for article (PubMed ID: 8366923)
21. Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection.
Ho YC; Sun HY; Chen MY; Hsieh SM; Sheng WH; Chang SC
J Microbiol Immunol Infect; 2008 Oct; 41(5):386-92. PubMed ID: 19122919
[TBL] [Abstract][Full Text] [Related]
22. Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS.
Jacobson JM; Hafner R; Remington J; Farthing C; Holden-Wiltse J; Bosler EM; Harris C; Jayaweera DT; Roque C; Luft BJ;
AIDS; 2001 Mar; 15(5):583-9. PubMed ID: 11316995
[TBL] [Abstract][Full Text] [Related]
23. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J
Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298
[TBL] [Abstract][Full Text] [Related]
24. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
Cohn JA; McMeeking A; Cohen W; Jacobs J; Holzman RS
Am J Med; 1989 May; 86(5):521-7. PubMed ID: 2712059
[TBL] [Abstract][Full Text] [Related]
26. Toxoplasmic encephalitis associated with meningitis in a heart transplant recipient.
Baliu C; Sanclemente G; Cardona M; Castel MA; Perez-Villa F; Moreno A; Cervera C
Transpl Infect Dis; 2014 Aug; 16(4):631-3. PubMed ID: 24903646
[TBL] [Abstract][Full Text] [Related]
27. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
Araujo FG; Suzuki Y; Remington JS
Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
[TBL] [Abstract][Full Text] [Related]
28. Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Iribarren JA; Arrizabalaga J; Garde C; Rodriguez-Arrondo F; Blanco A
Arch Intern Med; 1992 Oct; 152(10):2139-40. PubMed ID: 1417389
[No Abstract] [Full Text] [Related]
29. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
31. [Value of magnetic resonance in the diagnostic definition of neurotoxoplasmosis and in the assessment of the response to pharmacological treatment].
Sparacia G; Brancatelli G; Sarno C; De Maria M; Lagalla R; Filosto L
Radiol Med; 1998; 96(1-2):23-8. PubMed ID: 9819614
[TBL] [Abstract][Full Text] [Related]
32. [Cerebral toxoplasmosis].
Ribera Pascuet E; López Aldeguer J; Pérez Elías MJ; Podzamczer Palter D
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():45-51. PubMed ID: 9859619
[TBL] [Abstract][Full Text] [Related]
33. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
[TBL] [Abstract][Full Text] [Related]
34. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
Colin J; Harie JC
J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
[TBL] [Abstract][Full Text] [Related]
35. Recognition and management of toxoplasmosis.
Heitman BB; Irizarry AF
Nurse Pract; 1997 Sep; 22(9):75, 79-82, 85-6 passim. PubMed ID: 9314166
[TBL] [Abstract][Full Text] [Related]
36. Severe toxoplasmic ventriculomeningoencephalomyelitis in two AIDS patients following treatment of cerebral toxoplasmic granuloma.
Artigas J; Grosse G; Niedobitek F; Kassner M; Risch W; Heise W
Clin Neuropathol; 1994; 13(3):120-6. PubMed ID: 8088031
[TBL] [Abstract][Full Text] [Related]
37. Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS.
Saba J; Morlat P; Raffi F; Hazebroucq V; Joly V; Leport C; Vildé JL
Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):853-6. PubMed ID: 8112357
[TBL] [Abstract][Full Text] [Related]
38. [Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Ragnaud JM; Morlat P; Dupon M; Lacoste D; Pellegrin JL; Chene G
Presse Med; 1993 May; 22(19):903-8. PubMed ID: 8378280
[TBL] [Abstract][Full Text] [Related]
39. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.
Porter SB; Sande MA
N Engl J Med; 1992 Dec; 327(23):1643-8. PubMed ID: 1359410
[TBL] [Abstract][Full Text] [Related]
40. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
